NCT02744261View on ClinicalTrials.gov

Developing Rectal USPE Measures for Suppositories (Project DRUM-S)

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

August 11, 2016

Primary Completion Date

April 13, 2017

Study Completion Date

April 1, 2022

Conditions
Microbicide Delivery System Perceptibility and Acceptability
Trial Locations (1)

02903

The Miriam Hospital Centers for Behavioral and Preventive Medicine, Providence

Sponsors
All Listed Sponsors
collaborator

ImQuest Pharmaceuticals, Inc.

INDUSTRY

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

The Miriam Hospital

OTHER